Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Promoting Pluripotency: A specialized mammalian cell can be set back to the pluripotent state either by transfer of the somatic cell nucleus into an oocyte or by delivery of exogenous pluripotency-associated transcription factors. Hou et al. (p. 651 , published online 18 July) developed an approach to induce pluripotency in somatic cells using a cocktail of small molecules. The ability to generate such chemically induced pluripotent stem cells may provide an alternate route for therapeutic cloning and for drug development in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developing a chemical alternative to mimic OSK’s rejuvenating effects could lower costs and shorten timelines in regenerative medicine development [26, 28–31].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [31]
In the citing paper
“Recent studies have demonstrated the potential of small molecule stimulation in facilitating chemical reprogramming by inducing an intermediate plastic state [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“These small molecules effectively target key signaling pathways involved in cellular reprogramming, benefiting both human and mouse somatic cells [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Self-citationSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.02.020 · Cited by 898
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Cited by
Items 201–300 of 1,005
Gene Targeting by Homologous Recombination
Reh, W. A., & Vásquez, K. M. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0005988.pub2 · Cited by 63
Direct Cardiac Reprogramming: From Developmental Biology to Cardiac Regeneration
Li, Q., & Srivastava, D. (2013) · Circulation Research · doi:10.1161/circresaha.112.300625 · Cited by 62
Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming
Fang, J., Hsueh, Y., Soto, J., Sun, W., Wang, J., Gu, Z., Khademhosseini, A., & Li, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b04837 · Cited by 63
Wnt Signaling in Cardiac Disease
Hermans, K. C. M., & Blankesteijn, W. M. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140060 · Cited by 61
Use of Induced Pluripotent Stem Cells to Recapitulate Pulmonary Alveolar Proteinosis Pathogenesis
Suzuki, T., Mayhew, C. N., Sallese, A., Chalk, C., Carey, B. C., Malik, P., Wood, R. E., & Trapnell, B. C. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1039oc · Cited by 61
Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules
Han, Y., Lim, Y. P., Duffieldl, M. D., Li, H., Liu, J., Manaph, N. P. A., Yang, M., Keating, D. J., & Zhou, X. (2015) · Stem Cells International · doi:10.1155/2016/4304916 · Cited by 61
Self-citationOSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells
Parenti, A., Halbisen, M. A., Wang, K., Latham, K., & Ralston, A. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.003 · Cited by 57
Vascular microphysiological systems to model diseases
Zhang, Q., Zhang, X., & Truskey, G. A. (2020) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2020.012 · Cited by 60
Self-citationCell‐Based Therapies for Degenerative Musculoskeletal Diseases
Yin, P., Jiang, Y., Fang, X., Wang, D., Li, Y., Chen, M., Deng, H., Tang, P., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202207050 · Cited by 60
Self-citationInduced pluripotent stem cell-derived vascular smooth muscle cells: methods and application
Dash, B. C., Jiang, Z., Suh, C. Y., & Qyang, Y. (2015) · Biochemical Journal · doi:10.1042/bj20141078 · Cited by 60
Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds
Dai, P., Harada, Y., & Takamatsu, T. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-39 · Cited by 60
Shang, F., Ming, L., Zhou, Z., Yu, Y., Sun, J., Ding, Y., & Jin, Y. J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.061 · Cited by 60
Mai, T., Markov, G. J., Brady, J. J., Palla, A., Zeng, H., Sebastiano, V., & Blau, H. M. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0136-x · Cited by 55
Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules
Lee, C., Robinson, M., & Willerth, S. M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00365 · Cited by 60
Transcriptome Analysis of Small Molecule–Mediated Astrocyte-to-Neuron Reprogramming
Ma, N., Yin, J.-C., & Chen, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00082 · Cited by 60
Genomic Instability of iPSCs and Challenges in Their Clinical Applications
Yoshihara, M., Oguchi, A., & Murakawa, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_2 · Cited by 60
Clinical Therapy Using iPSCs: Hopes and Challenges
Lu, X., & Zhao, T. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.002 · Cited by 60
Self-citationMultifaceted Regulation of Somatic Cell Reprogramming by mRNA Translational Control
Tahmasebi, S., Alain, T., Rajasekhar, V. K., Zhang, J.-P., Prager‐Khoutorsky, M., Khoutorsky, A., Dogan, Y., Gkogkas, C. G., Petroulakis, E., Sylvestre, A., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.005 · Cited by 59
Stem Cell Therapy for Neonatal Brain Injury
Fleiss, B., Guillot, P. V., Titomanlio, L., Baud, O., Hagberg, H., & Gressèns, P. (2013) · Clinics in Perinatology · doi:10.1016/j.clp.2013.09.002 · Cited by 59
Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells
Csöbönyeiová, M., Polák, Š., & Danišovič, L. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0459 · Cited by 52
Transcriptional Control of Somatic Cell Reprogramming
Xu, Y., Zhang, M., Li, W., Zhu, X., Bao, X., Qin, B., Hutchins, A. P., & Esteban, M. A. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.003 · Cited by 59
Higuchi, A., Kumar, S. S., Ling, Q., Alarfaj, A. A., Munusamy, M. A., Murugan, K., Hsu, S.-T., Benelli, G., & Umezawa, A. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.09.002 · Cited by 59
Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease
Connor, B. J. (2017) · Stem Cells · doi:10.1002/stem.2747 · Cited by 59
Cellular trajectories and molecular mechanisms of iPSC reprogramming
Apostolou, E., & Stadtfeld, M. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.06.002 · Cited by 61
Reversibility of irreversible aging
Galkin, F., Zhang, B., Dmitriev, S. E., & Gladyshev, V. N. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.008 · Cited by 51
Hu, J., Yang, Z.-Y., Wang, J., Yu, J., Guo, J., Liu, S., Qian, C., Song, L., Wu, Y., & Cheng, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148994 · Cited by 58
Concise Review: Genomic Instability in Human Stem Cells: Current Status and Future Challenges
Oliveira, P. H., Silva, C. L., & Cabral, J. M. S. (2014) · Stem Cells · doi:10.1002/stem.1796 · Cited by 52
Kwon, D., Kim, J., Cha, B.-H., Park, K., Han, I., Park, K., Bae, H., Han, M., Kim, K., & Lee, S. (2016) · Cell Transplantation · doi:10.3727/096368915x689703 · Cited by 58
Chemical compound-based direct reprogramming for future clinical applications.
Takeda, Y., Harada, Y., Yoshikawa, T., & Dai, P. (2018) · Bioscience Reports · doi:10.1042/bsr20171650 · Cited by 57
Walia, M., Ho, P. M., Taylor, S., Ng, A. J., Gupte, A., Chalk, A. M., Zannettino, A. C. W., Martin, T. J., & Walkley, C. R. (2016) · eLife · doi:10.7554/elife.13446 · Cited by 57
The vascular adventitia: An endogenous, omnipresent source of stem cells in the body
Wörsdörfer, P., Mekala, S. R., Bauer, J., Edenhofer, F., Küerten, S., & Ergün, S. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.017 · Cited by 57
Small molecule-induced cellular fate reprogramming: promising road leading to Rome
Li, X., Xu, J., & Deng, H. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.05.004 · Cited by 47
Self-citationMethods and applications of CRISPR/Cas system for genome editing in stem cells
Yang, G., & Huang, X. (2019) · Cell Regeneration · doi:10.1016/j.cr.2019.08.001 · Cited by 56
Concise Review: Stem Cell-Based Approaches to Red Blood Cell Production for Transfusion
Shah, S., Huang, X., & Cheng, L. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0054 · Cited by 56
Li, J., Song, W., Pan, G., & Zhou, J. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0050-z · Cited by 56
Ogorevc, J., Orehek, S., & Dovč, P. (2016) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-016-0070-3 · Cited by 56
A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells
Zheng, J., Choi, K., Kang, P. J., Hyeon, S., Kwon, S., Moon, J.-H., Hwang, I.-S., Kim, Y. I., Kim, Y. S., Yoon, B. S., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.080 · Cited by 56
Li, K., Zhong, X., Yang, S., Luo, Z., Li, K. V., Liu, Y., Cai, S., Gu, H., Lu, S., Zhang, H., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.032 · Cited by 56
Self-citationSmall Molecules that Promote Self-Renewal of Stem Cells and Somatic Cell Reprogramming
Chen, G., Guo, Y., Li, C., Li, S., & Wan, X. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09965-w · Cited by 56
Tan, F., Qian, C., Tang, K., Abd-Allah, S. M., & Jing, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609016 · Cited by 55
Small Molecule Screening in Human Induced Pluripotent Stem Cell-derived Terminal Cell Types
Engle, S. J., & Vincent, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.529156 · Cited by 56
The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells
Brix, J., Zhou, Y., & Luo, Y. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.10.001 · Cited by 55
Pluripotent stem cells and livestock genetic engineering
Soto, D. A., & Ross, P. J. (2016) · Transgenic Research · doi:10.1007/s11248-016-9929-5 · Cited by 55
Small molecules increase direct neural conversion of human fibroblasts
Pfisterer, U., Ek, F., Lang, S., Soneji, S., Olsson, R., & Parmar, M. (2016) · Scientific Reports · doi:10.1038/srep38290 · Cited by 55
Schaefer, T., Steiner, R., & Lengerke, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144902 · Cited by 55
Retraction Note: Stimulus-triggered fate conversion of somatic cells into pluripotency
Obokata, H., Wakayama, T., Sasai, Y., Kojima, K., Vacanti, M. P., Niwa, H., Yamato, M., & Vacanti, C. A. (2014) · Nature · doi:10.1038/nature13598 · Cited by 55
Sart, S., Agathos, S. N., & Li, Y. (2014) · Biochemical Engineering Journal · doi:10.1016/j.bej.2014.01.005 · Cited by 54
Self-citationCellular Reprogramming as a Therapeutic Target in Cancer
Xiong, S., Ye, F., & Cheng, L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.05.001 · Cited by 54
Chromatin accessibility dynamics during cell fate reprogramming
Li, D., Shu, X., Zhu, P., & Pei, D. (2021) · EMBO Reports · doi:10.15252/embr.202051644 · Cited by 54
Transitions between epithelial and mesenchymal states during cell fate conversions
Li, X., Pei, D., & Zheng, H. (2014) · Protein & Cell · doi:10.1007/s13238-014-0064-x · Cited by 52
Rony, I. K., Baten, A., Bloomfield, J. A., Islam, M. E., Billah, M. M., & Islam, K. M. D. (2015) · Cell Proliferation · doi:10.1111/cpr.12162 · Cited by 53
Back to the future: how human induced pluripotent stem cells will transform regenerative medicine
Svendsen, C. N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt379 · Cited by 53
Cai, S., Han, L., Ao, Q., Chan, Y., & Shum, D. K. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0424 · Cited by 53
Pluripotent Stem Cells: The Last 10 Years
Kimbrel, E. A., & Lanza, R. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0117 · Cited by 53
Human neural progenitors derived from integration-free iPSCs for SCI therapy
Liu, Y., Zheng, Y., Li, S., Xue, H., Schmitt, K., Hergenroeder, G. W., Wu, J., Zhang, Y., Kim, D., & Cao, Q. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.01.004 · Cited by 53
Modeling rare diseases with induced pluripotent stem cell technology
Anderson, R. H., & Francis, K. R. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.01.001 · Cited by 53
Ye, H., & Wang, Q. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494589 · Cited by 53
LSD1: Expanding Functions in Stem Cells and Differentiation
Martinez‐Gamero, C., Malla, S., & Aguiló, F. (2021) · Cells · doi:10.3390/cells10113252 · Cited by 53
Stem Cell Therapies for Treatment of Liver Disease
Nicolas, C. T., Wang, Y., Luebke-Wheeler, J. L., & Nyberg, S. L. (2016) · Biomedicines · doi:10.3390/biomedicines4010002 · Cited by 52
Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency
van den Hurk, M., Kenis, G., Bardy, C., van den Hove, D. L., Gage, F. H., Steinbusch, H. W., & Rutten, B. P. (2016) · Epigenomics · doi:10.2217/epi-2016-0032 · Cited by 40
Roles of vitamins in stem cells
Godoy-Parejo, C., Deng, C., Zhang, Y., Liu, W., & Chen, G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03352-6 · Cited by 52
Non-Viral Generation of Marmoset Monkey iPS Cells by a Six-Factor-in-One-Vector Approach
Debowski, K., Warthemann, R., Lentes, J., Salinas, G., Dressel, R., Langenstroth, D., Gromoll, J., Sasaki, E., & Behr, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118424 · Cited by 51
Failure to replicate the STAP cell phenomenon
Angeles, A. D. L., Ferrari, F., Fujiwara, Y., Mathieu, R., Lee, S., Lee, S., Tu, H.-C., Ross, S. J., Chou, S. S., Nguyen, M., et al. (2015) · Nature · doi:10.1038/nature15513 · Cited by 51
Self-citationArtificial meat? Feasible approach based on the experience from cell culture studies
Orzechowski, A. (2015) · Journal of Integrative Agriculture · doi:10.1016/s2095-3119(14)60882-0 · Cited by 51
p53 switches off pluripotency on differentiation
Lin, T., & Lin, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0498-1 · Cited by 51
Recent technological updates and clinical applications of induced pluripotent stem cells
Diecke, S., Jung, S. M., Lee, J., & Ju, J. H. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.5.547 · Cited by 51
In vitro neurogenesis: development and functional implications of iPSC technology
Compagnucci, C., Nizzardo, M., Corti, S. P., Zanni, G., & Bertini, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1511-1 · Cited by 50
Current Progress in Stem Cell-Based Gene Therapy for Articular Cartilage Repair
Frisch, J., Venkatesan, J. K., Rey‐Rico, A., Madry, H., & Cucchiarini, M. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140922112326 · Cited by 50
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
(2025) · doi:10.1038/s44321-025-00265-9 · Cited by 49
Therapeutic gene regulation using pyrrole–imidazole polyamides
Yu, Z., Pandian, G. N., Hidaka, T., & Sugiyama, H. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.001 · Cited by 49
Lee, K., Chen, Y., Yoshitomi, T., Kawazoe, N., Yang, Y., & Chen, G. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000617 · Cited by 49
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
(2022) · doi:10.1101/2022.08.29.505222 · Cited by 49
Qian, X., Zhu, L., Xu, M., Liu, H., Yu, X., Shao, Q., & Qin, J. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110588 · Cited by 48
Biomaterials control of pluripotent stem cell fate for regenerative therapy
Pérez, R. A., Choi, S., Han, C., Kim, J., Shim, H., Leong, K. W., & Kim, H. (2016) · Progress in Materials Science · doi:10.1016/j.pmatsci.2016.05.003 · Cited by 48
Pluripotent stem cells: induction and self-renewal
Abu‐Dawud, R., Graffmann, N., Ferber, S., Wruck, W., & Adjaye, J. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0213 · Cited by 48
3D printing of chemical-empowered tendon stem/progenitor cells for functional tissue repair
Zhang, Y., Lei, T., Tang, C., Chen, Y., Liao, Y., Ju, W., Zhang, H., Zhou, B., Liang, R., Zhang, T., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120722 · Cited by 48
Self-citationPreclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds
Heublein, H., Bader, A., & Giri, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.005 · Cited by 48
A rapid chemical reprogramming system to generate human pluripotent stem cells
Wang, Y., Peng, F., Yang, Z., Cheng, L., Cao, J., Fu, X., He, H., Cai, R., Zeng, W., Dong, Y., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-024-01799-8 · Cited by 47
Self-citationCombinatorial MAPLE gradient thin film assemblies signalling to human osteoblasts
Axente, E., Sima, F., Sima, L. E., Erginer, M., Eroğlu, M. S., Serban, N., Ristoscu, C., Petrescu, S. M., Öner, E. T., & Mihailescu, I. N. (2014) · Biofabrication · doi:10.1088/1758-5082/6/3/035010 · Cited by 47
Pandian, G. N., Sato, S., Chandran, A., Taniguchi, J., Takashima, K., Syed, J., Han, L. K., Saha, A., Bando, T., Nagase, H., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500724t · Cited by 47
DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice
Zheng, S., Xiao, L., Liu, Y., Wang, Y., Cheng, L. Z., Zhang, J., Yan, N., & Chen, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0349-8 · Cited by 47
How to reprogram human fibroblasts to neurons
Xu, Z., Su, S., Zhou, S., Yang, W., Deng, X., Sun, Y., Li, L., & Li, Y. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00476-2 · Cited by 47
Self-citationOstrovidov, S., Shi, X., Sadeghian, R. B., Salehi, S., Fujie, T., Bae, H., Ramalingam, M., & Khademhosseini, A. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9618-4 · Cited by 47
Regenerative strategies for kidney engineering
Montserrat, N., Garreta, E., & Belmonte, J. C. I. (2016) · FEBS Journal · doi:10.1111/febs.13704 · Cited by 47
Stem Cells for Modeling and Therapy of Parkinson's Disease
Zhang, Q., Chen, W.-L., Tan, S., & Lin, T. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.116 · Cited by 47
Self-citationTarget neutrophil heterogeneity and plasticity in cancer
Ye, F., Guang, L., Li, H., & Cheng, L. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01731-0 · Cited by 47
Self-citationFabrication of cellulose aerogel from wheat straw with strong absorptive capacity
Jian LI, C. W., Wan, C., Yun, L. U., & Qingfeng, S. U. N. (2014) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2014004 · Cited by 46
A dual role of Erk signaling in embryonic stem cells
Ma, X., Chen, H., & Chen, L. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2015.12.008 · Cited by 46
Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation
Lewandowski, J., & Kurpisz, M. K. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0385-y · Cited by 48
Regenerating the human heart: direct reprogramming strategies and their current limitations
Ghiroldi, A., Piccoli, M., Ciconte, G., Pappone, C., & Anastasia, L. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0655-9 · Cited by 46
Liu, J., Brzeszczyńska, J., Samuel, K., Black, J., Palakkan, A. A., Anderson, R. A., Gallagher, R., & Ross, J. A. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.08.004 · Cited by 45
Pluripotent Stem Cell Derived Cardiomyocytes for Cardiac Repair
Lundy, S. D., Gantz, J. A., Pagan, C. M., Filice, D., & Laflamme, M. A. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0319-0 · Cited by 45
Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
Sachamitr, P., Hackett, S., & Fairchild, P. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00176 · Cited by 45
Looking to the future following 10 years of induced pluripotent stem cell technologies
Li, M., & Belmonte, J. C. I. (2016) · Nature Protocols · doi:10.1038/nprot.2016.108 · Cited by 45
Xu, X., Shi, D., Liu, Y., Yao, Y., Dai, J., Xu, Z., Chen, D., Teng, H., & Jiang, Q. Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4474 · Cited by 45
Engineering cell identity: establishing new gene regulatory and chromatin landscapes
Guo, C., & Morris, S. A. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.06.011 · Cited by 45
Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications
Li, Y., Li, L., Chen, Z., Gao, G., Yao, R., & Sun, W. (2017) · Biofabrication · doi:10.1088/1758-5090/aa7e9a · Cited by 45
Self-citationGuo, R., Tang, W., Yuan, Q., Hui, L., Wang, X., & Xie, X. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.013 · Cited by 43
Arrayed mutant haploid embryonic stem cell libraries facilitate phenotype-driven genetic screens
Liu, G., Wang, X. L., Liu, Y., Zhang, M., Cai, T., Shen, Z., Jia, Y., & Huang, Y. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx857 · Cited by 45
Transcription factors: Time to deliver
Ulasov, A. V., Rosenkranz, A. A., & Sobolev, A. S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.004 · Cited by 45
Metadata
- Authors
- Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., & Deng, H.
- Affiliations
- Peking University (CN)
- Beijing Vitalstar Biotechnology Co., Ltd., Beijing 100012, China.
- Corresponding author
- Hou, Pingping
- Li, Yanqin
- Zhang, Xu
- Liu, Chun
- Guan, Jingyang
- Li, Honggang
- Zhao, Ting
- Ye, Junqing
- Yang, Weifeng
- Liu, Kang
- Ge, Jian
- Xu, Jun
- Zhang, Qiang
- Zhao, Yang
- Deng, Hongkui
- ORCID
- Venue
- Science
- Published
- 2013-08-09
- Volume
- 341
- Issue
- 6146
- Pages
- 651-654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101569447
- Cited by
- 1,402
- References
- 38
- Citations by year
- 2026: 51 · 2025: 76 · 2024: 78 · 2023: 77 · 2022: 72 · 2021: 85 · 2020: 84 · 2019: 84 · 2018: 114 · 2017: 114 · 2016: 161 · 2015: 165 · 2014: 182 · 2013: 59
- FWCI
- 84.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Microsoft Research
- York University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- pluripotent stem cells, chemical reprogramming, small molecules, somatic cell reprogramming, induced pluripotent stem cells, germline transmission, epigenetic status, differentiation potential, master genes
- MeSH terms
- Animals, Fibroblasts, Mice, Inbred C57BL, Mice, Inbred ICR, Promoter Regions, Genetic, Cadherins, Gene Expression Profiling, Green Fluorescent Proteins, Octamer Transcription Factor-3, Mice, Small Molecule Libraries, Induced Pluripotent Stem Cells, Epithelial-Mesenchymal Transition, Cell Engineering, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.